Does the addition of recombinant LH in WHO group II anovulatory women over-responding to FSH treatment reduce the number of developing follicles? A dose-finding study

Author： Hugues J.N.  

Publisher： Oxford University Press

ISSN： 1460-2350

Source： Human Reproduction, Vol.20, Iss.3, 2005-03, pp. : 629-635

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Predicting the FSH threshold dose in women with WHO Group II anovulatory infertility failing to ovulate or conceive on clomiphene citrate

By Nyboe Andersen Anders   Balen Adam   Platteau Peter   Devroey Paul   Helmgaard Lisbeth   Arce Joan-Carles  

Human Reproduction, Vol. 23, Iss. 6, 2008-06 ,pp. : 1424-1430

Oxford University Press

Access to resources Recommend Favorite

Highly purified FSH is as efficacious as recombinant FSH for ovulation induction in women with WHO Group II anovulatory infertility: a randomized controlled non-inferiority trial

By Balen Adam   Platteau Peter   Andersen Anders Nyboe   Devroey Paul   Helmgaard Lisbeth   Arce Joan-Carles  

Human Reproduction, Vol. 22, Iss. 7, 2007-07 ,pp. : 1816-1823

Oxford University Press

Access to resources Recommend Favorite

Similar ovulation rates, but different follicular development with highly purified menotrophin compared with recombinant FSH in WHO Group II anovulatory infertility: a randomized controlled study

By Platteau Peter   Andersen Anders Nyboe   Balen Adam   Devroey Paul   Sørensen Per   Helmgaard Lisbeth   for the Menopur Ovulation Induction (MOI) Study Group  

Human Reproduction, Vol. 21, Iss. 7, 2006-07 ,pp. : 1798-1804

Oxford University Press

Access to resources Recommend Favorite

Reproductive endocrinology. The effectiveness and safety of recombinant human LH to support follicular development induced by recombinant human FSH in WHO group I anovulation: evidence from a multicentre study in Spain

By Burgués S.  

Human Reproduction, Vol. 16, Iss. 12, 2001-12 ,pp. : 2525-2532

Oxford University Press

Access to resources Recommend Favorite

Dose-finding study of daily GnRH antagonist for the prevention of premature LH surges in IVF/ICSI patients: optimal changes in LH and progesterone for clinical pregnancy

By Huirne Judith A.F.   van Loenen Andre C.D.   Schats Roel   McDonnell Joseph   Hompes Peter G.A.   Schoemaker Joop   Homburg Roy   Lambalk Cornelis B.  

Human Reproduction, Vol. 20, Iss. 2, 2005-02 ,pp. : 359-367

Oxford University Press

Access to resources Recommend Favorite